rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTACTTACCGTTCCGATACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	73	0.02741269245212167		55	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-06	01	5	3	6	5	16	5	23	34	53	50	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-06	TCRBV09-01		TCRBJ02-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCGGTGGGAACCGATACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSRWEPIQSRANVLTF	In	VDJ	1	54	0.020277882087870822	0.03708791208791209	54	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-06	01	6	0	8	5	5	14	24	35	44	40	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRWEPIQSRANVLTF+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01		TCRBJ02-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTGGAGTGACAGGGGGTGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	55	0.020653398422831395		46	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	1	6	7	2	24	36	52	43	54														X+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGGATGGCACTTCCTACGAGCAGTACTTTGGGCCG	CASSLDGTSYEQYF	In	VDJ	1	37	0.013894104393541119	0.025412087912087912	42	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-07	01	3	1	8	19	0	25	18	-1	35	32	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGTSYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01		TCRBJ02-07*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGTACAACAGGGCTTCGGTGGAAACACCATATATTTTGGAGAG	CASSVQQGFGGNTIYF	In	VDJ	1	37	0.013894104393541119	0.025412087912087912	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	3	3	5	6	19	31	42	36	48													Vb 5.1	CASSVQQGFGGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCCAAAGGATAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	32	0.012016522718738265		46	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-02	01	3	1	8	2	6	2	25	39	48	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01		TCRBJ02-02*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCACGGGATCAGCCCCAGCATTTTGGTGAT	CASSMARDQPQHF	In	VDJ	1	33	0.012392039053698836	0.022664835164835164	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	8	4	5	4	0	27	41	-1	45	49			01,02			01,02							Vb 17	CASSMARDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGTTTGGATCAGCCCCAGCATTTTGGTGAT	CASSMGLDQPQHF	In	VDJ	1	40	0.015020653398422831	0.027472527472527472	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	3	0	9	5	0	5	27	-1	44	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGLDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTACTCTCCTGACGGGCGCGGACACTGAAGCTTTCTTTGGACAA	CASSTLLTGADTEAFF	In	VDJ	1	38	0.01426962072850169	0.0260989010989011	48	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	5	8	0	3	11	4	23	35	50	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSTLLTGADTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCTGACTCACAGGGTGAGGTAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSP*LTG*GSSYNSPLHF	Stop	VDJ	1	26	0.00976342470897484		60	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	3	0	9	8	18	30	45	39	53	TCRBV07,TCRBV11													CASSP*LTG*GSSYNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGCTTATTTGCAGGGGGCGAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLFAGGESSYNEQFF	In	VDJ	1	26	0.00976342470897484	0.017857142857142856	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	0	0	4	5	18	33	45	37	50	TCRBV11,TCRBV12													CASSLFAGGESSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGCGGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	27	0.010138941043935411		41	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	2	1	1	0	26	38	-1	39	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGAGCGTGTCAGGGACCTGAAGCTTTCTTTGGACAA	CRACQGPEAFF	In	VDJ	1	28	0.010514457378895982	0.019230769230769232	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	9	0	7	6	9	0	26	31	-1	40	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CRACQGPEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTACACGAGTGGGGCCCTCCACTTTGGGAAC	CASSYTSGALHF	In	VDJ	1	29	0.010889973713856553	0.019917582417582416	36	TCRBV12						TCRBJ01	TCRBJ01-06	01	6	6	2	14	10	0	26	37	-1	47	51		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYTSGALHF+TCRBV12-X+TCRBJ01-06	TCRBV12		TCRBJ01-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGTACATGGCTGAAAGACCTATGGCTACACCTTCGGTTCG	CASSVHG*KTYGYTF	Stop	VDJ	1	29	0.010889973713856553		45	TCRBV24						TCRBJ01	TCRBJ01-02	01	5	2	7	4	13	0	24	37	-1	50	53		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVHG*KTYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAATGATCCCGGGACGGGATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	31	0.011641006383777694		46	TCRBV24						TCRBJ01	TCRBJ01-06	01	3	0	7	5	3	3	24	39	47	42	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCTCCACGACAGGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSSTTGGSTDTQYF	In	VDJ	1	31	0.011641006383777694	0.021291208791208792	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	1	0	4	1	19	32	45	36	46	TCRBV05,TCRBV11													CASSSTTGGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGCGAGGACGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDGEDGGNTGELFF	In	VDJ	1	32	0.012016522718738265	0.02197802197802198	54	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	2	1	9	0	26	43	-1	52	58		TCRBV03-01,TCRBV03-02												CASSQDGEDGGNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01*01	TCRBJ02-02*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACGCGGAGAGGATGGGCTAGAGACCCAGTACTTCGGGCCA	CASRRGEDGLETQYF	In	VDJ	1	33	0.012392039053698836	0.022664835164835164	45	TCRBV03						TCRBJ02	TCRBJ02-05	01	6	8	0	4	13	1	26	37	54	50	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRGEDGLETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTGGCGGGGGGGCTACGAGCAGTACTTCGGGCCG	CATSWRGGYEQYF	In	VDJ	1	33	0.012392039053698836	0.022664835164835164	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	7	0	3	2	0	24	36	-1	38	47		TCRBV24-01,TCRBV24-or09_02												CATSWRGGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCGCCTTCACCAATCTCGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	35	0.013143071723619977		56	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	6	5	15	5	19	31	50	46	55		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ02-06	TCRBV05	TCRBD01-01*01	TCRBJ02-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGGGCCGGCCGGACGGGACGTCGGACCTATAATTCACCCCTCCACTTTGGGAAC	CASRAGRTGRRTYNSPLHF	In	VDJ	1	39	0.01464513706346226	0.026785714285714284	57	unresolved						TCRBJ01	TCRBJ01-06	01	6	0	7	2	12	6	24	35	52	47	58	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAGRTGRRTYNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATTTGTAGTCCATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	40	0.015020653398422831		52	TCRBV03						TCRBJ01	TCRBJ01-05	01	5	9	0	5	17	3	26	38	58	55	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-05	TCRBV03		TCRBJ01-05*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCGGGGACAGGGGGTCGAGCAGTACTTCGGGCCG	CASSRGQGVEQYF	In	VDJ	1	42	0.015771686068343973	0.028846153846153848	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	1	6	3	1	24	35	49	38	50	TCRBV06,TCRBV10													CASSRGQGVEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGAAAGTCCCATTTCAGGCTGACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	42	0.015771686068343973		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	4	5	15	3	26	39	58	54	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCTCCCGGGACTAGCGCTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	44	0.016522718738265114		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	6	2	4	2	26	38	52	42	54	TCRBV03,TCRBV09					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAAGCTCCGGGACAGAGGTCACAGATACGCAGTATTTTGGCCCA	CSAPSSGTEVTDTQYF	In	VDJ	1	45	0.016898235073225687	0.030906593406593408	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	2	9	4	26	35	51	44	55		TCRBV20-01,TCRBV20-or09_02												CSAPSSGTEVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCGATCGGAATCTTCGGAGACCCAGTACTTCGGGCCA	XASSRSESSETQYF	In	VDJ	1	48	0.018024784078107398	0.03296703296703297	42	unresolved						TCRBJ02	TCRBJ02-05	01	4	1	8	5	4	7	23	36	43	40	50	TCRBV01,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSRSESSETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCGCACGATCCATTTACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	1	55	0.020653398422831395		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	6	5	15	5	26	38	56	53	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCCCTGGGGTAGCCAAAAACATTCAGTACTTCGGCGCC	CSAIPGVAKNIQYF	In	VDJ	1	62	0.02328201276755539	0.042582417582417584	42	TCRBV20						TCRBJ02	TCRBJ02-04	01	4	6	2	0	5	1	26	36	45	41	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIPGVAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20		TCRBJ02-04*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGTCTTCAGCAACGGATAGGGACGACTAATGAAAAACTGTTTTTTGGCAGT	CASLQQRIGTTNEKLFF	In	VDJ	1	62	0.02328201276755539	0.042582417582417584	51	unresolved						TCRBJ01	TCRBJ01-04	01	10	0	7	2	17	1	24	31	53	48	54	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASLQQRIGTTNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTGACCCGACAGGGGGGCACTGAAGCTTTCTTTGGACAA	CASSLTRQGGTEAFF	In	VDJ	1	63	0.02365752910251596	0.04326923076923077	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	4	7	1	26	38	54	45	55		TCRBV12-03,TCRBV12-04												CASSLTRQGGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAAATCAGGGATGAAAAACTGTTTTTTGGCAGT	CAISEIRDEKLFF	In	VDJ	1	68	0.025535110777318813	0.046703296703296704	39				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	3	6	2	0	23	38	-1	40	45	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISEIRDEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAATGCTAGTTATAACAGGGTCCCTGGAAACACCATATATTTTGGAGAG	CNASYNRVPGNTIYF	In	VDJ	1	70	0.026286143447239955	0.04807692307692308	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	3	3	2	5	3	26	37	48	42	51		TCRBV20-01,TCRBV20-or09_02												CNASYNRVPGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGAGGACAGGGAGACAGAAACACCATATATTTTGGAGAG	CSARRGQGDRNTIYF	In	VDJ	1	84	0.031543372136687946	0.057692307692307696	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	3	5	3	5	26	38	49	41	54		TCRBV20-01,TCRBV20-or09_02												CSARRGQGDRNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGAGGCCCTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	87	0.032669921141569656		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	11	1	5	1	18	26	38	43	39	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGAGAGGGCGGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSQERAGGYNEQFF	In	VDJ	1	109	0.04093128051070222	0.07486263736263736	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	1	4	4	1	23	40	52	44	53	TCRBV04,TCRBV23													CASSQERAGGYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGGCAGCCAGAGCCATCCATTTACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	2	125	0.04693954187007135		53	TCRBV03						TCRBJ01	TCRBJ01-03	01	9	3	6	5	20	5	26	34	57	54	62		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
ACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGGCAGTACGAACAGTAGCCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	27	0.010138941043935411		50	TCRBV08	TCRBV08-02	01				TCRBJ02	TCRBJ02-06	01	6	3	5	5	5	13	31	39	48	44	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV08-02+TCRBJ02-06	TCRBV08-02*01		TCRBJ02-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTGACTAAGGCTTATTTAAAAGACCTATGGCTACACCTTCGGTTCG	CASS*LRLI*KTYGYTF	Stop	VDJ	1	93	0.034923019151333085		51	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	2	9	4	0	17	26	-1	44	39	61						01,02								CASS*LRLI*KTYGYTF+TCRBV06-07+TCRBJ01-02	TCRBV06-07*01	TCRBD02-01	TCRBJ01-02*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CGAAGCTTGAGGATTCAGCAGTGTATTTTTGTGCCAGCAGCCAATCTATAATGGCTTTCTTTGGACAA	CASSQSIMAFF	In	VDJ	1	45	0.016898235073225687	0.030906593406593408	33	TCRBV16	TCRBV16-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	5	9	11	0	5	29	-1	48	46	53			01,02			01,02								CASSQSIMAFF+TCRBV16-01+TCRBJ01-01	TCRBV16-01	TCRBD02-01	TCRBJ01-01*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTATGGGCTACTAGCATACAAAGCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	94	0.03529853548629366		52	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	3	7	5	8	9	25	34	48	42	57						01,02							Vb 4	X+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD02-01	TCRBJ02-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACTCGCCCGATTCACCCCTCCACTTTGGGAAC	CASSYSPDSPLHF	In	VDJ	1	28	0.010514457378895982	0.019230769230769232	39	TCRBV06	unresolved					TCRBJ01	TCRBJ01-06	01	0	10	0	8	0	3	23	-1	42	40	45		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSPDSPLHF+TCRBV06-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAACTGGGGGAGACGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSNWGRRQSRANVLTF	In	VDJ	1	59	0.022155463762673678	0.040521978021978024	54	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	5	6	1	5	4	13	18	30	39	34	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSNWGRRQSRANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATGTGCGCTCTGCGTACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	63	0.02365752910251596		52	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	7	3	6	5	14	5	18	28	45	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTATACTAGGCAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	141	0.05294780322944048		53	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-06	01	4	1	6	5	10	5	26	39	54	49	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01		TCRBJ02-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGAGGTCGTCGGGCCAACGTCCTGACTTTCGGGGCC	CTSRGRRANVLTF	In	VDJ	1	42	0.015771686068343973	0.028846153846153848	39	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	6	5	4	5	0	5	23	-1	37	34	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSRGRRANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGAAATGACGTGTGCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	88	0.03304543747653023		52	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	6	2	7	5	4	14	23	34	41	38	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCCGGGCTCTGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPRALGANVLTF	In	VDJ	1	33	0.012392039053698836	0.022664835164835164	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	5	8	0	4	4	4	23	35	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRALGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGACAGGGTATGGCTACACCTTCGGTTCG	CASSYSRTGYGYTF	In	VDJ	1	41	0.015396169733383402	0.02815934065934066	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	5	2	0	23	40	-1	42	50														CASSYSRTGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASSEGDYNEQFF	In	VDJ	1	65	0.024408561772437103	0.044642857142857144	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	5	1	3	1	1	23	35	42	36	43														CASSEGDYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	0511A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				53	28	21	2	0	51	31	17	3	0	2663	1456	1059	148	0	0.0203041844	4.85360527	0.0280604362	5.51325464				659	0.0539086536	0.0748626366	0.0529478043	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:15	Age (Range):45-65 Years (Late Adulthood),Age:60 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 1158,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 385,type of chemo:carbo/taxol	0.5283018723928338	MSKCC- Snyder- P01-02		36.0	
